Thomas Harnly, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 |
Kevin Au, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5461 |
Thomas R. Reagan, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 |
Dr. David Alan Simonowitz, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 22621 Ne 114th St, Redmond, WA 98053 Phone: 425-890-4653 |
News Archive
MAXIMUS, Inc., a leading provider of government services worldwide, and Connecture, the leader in Web-based marketplaces and administration solutions for health insurance distribution, announced today that the two companies have entered into a strategic alliance.
Republicans aren't softening their tough criticism of the health law even as they seek Democratic allies to join them in their bid to repeal the overhaul.
Physician-scientists at Memorial Sloan-Kettering Cancer Center are studying a novel approach to treat metastatic melanoma, known as immunotherapy, which uses the body's own immune system to attack cancer. Presented today at the American Society of Clinical Oncology annual meeting, encouraging new data shows - for the first time - a survival benefit in metastatic melanoma patients using an immunotherapy discovered and clinically investigated by researchers at Memorial Sloan-Kettering.
Ruthigen Inc., a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee to begin enrolling patients in the Company's planned Phase 1/2 clinical trial.
BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for human genome analysis. Current investors, Battelle Ventures, Domain Associates, Gund Investment Corporation, participated in the financing.
› Verified 7 days ago